The challenge is the administrative burden on providers because there are no agreed-upon standards and measures, say Inovalon SVPs Kristopher Volrath and Karly Rowe.

Optum, a subsidiary of UnitedHealth Group, has submitted an all-cash proposal to the Board of Directors of Amedisys in a bid to combine with the home health, hospice and high-acuity care provider in a transaction estimated at $3.26 billion. The $100 per share all-cash transaction represents a 26% premium over Amedisys’ most recent closing share […]

States have begun to unwind the COVID-19 emergency continuous enrollment provision and resumed Medicaid disenrollments, and early data shows that more than half a million enrollees have already been disenrolled, with close to 250,000 in Florida alone.

In a collaboration with AT&T, the Cherish device is on when it’s plugged in, with no app to download or password needed, says CEO and founder Sumit Nagpal.

Artificial intelligence and machine learning can be applied to dense clinical data to outline the correct care path for an individual and then for populations, says John Gaines, VP of marketing at Cohere Health.

Better data helps providers, payers and patients, said Eric Demers, CEO of Madaket, which aims to take waste out of healthcare administration.  More data allows for greater digitization of patient information and there’s now an emphasis to use real-time accurate data in the revenue cycle and on the finance side, he said. 

Friday Health Plans of Georgia will be placed into receivership due to its reported insolvency and inability to raise additional funds from outside investors, according to the state’s Office of Commissioner of Insurance and Safety Fire.

Hospital finances broke even in April amid a continuing trend of high expenses, plus the unwinding of the Medicaid continuous coverage requirement of the COVID-19 public health emergency, according to the latest National Hospital Flash Report from Kaufman Hall.

Virtualists can handle the three Rs that take up 50% of a physician’s time: routine, repeatable and rules-based care, says Dr. Lyle Berkowitz, CEO of KeyCare.

The Centers for Medicare and Medicaid Services will cover the high cost of Alzheimer’s drugs if the Food and Drug Administration grants traditional approval and when a physician and clinical team participates in the collection of evidence about how these drugs work in the real world, also known as a registry.